Polydex Pharmaceuticals (OTCMKTS:POLXF) Stock Price Crosses Below Two Hundred Day Moving Average of $0.96

Polydex Pharmaceuticals Limited (OTCMKTS:POLXFGet Rating) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.96 and traded as low as $0.91. Polydex Pharmaceuticals shares last traded at $0.95, with a volume of 24,950 shares trading hands.

The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.01 and a current ratio of 4.00. The firm has a fifty day moving average price of $0.94 and a 200 day moving average price of $0.96. The firm has a market capitalization of $3.26 million, a price-to-earnings ratio of -13.57 and a beta of 0.46.

About Polydex Pharmaceuticals (OTCMKTS:POLXF)

Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry.

Featured Stories

Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.